← All organizations

Evolus, Inc.

Academic/HospitalContributed to NMEWebsite ↗

Also known as: Evolus, iInc. | Evolus Inc. | Evolus, Inc. | EVOLUS INC

Highest phase reached

Phase 4

First clinical trial

Aug 1, 2014

First marketed drug

Feb 1, 2019

Last known activity

May 14, 2025

Timeline

2010s

  1. Feb 1, 2019

    prabotulinumtoxinA— Marketing Organization

  2. Feb 1, 2019

    prabotulinumtoxinA— NDA Organization

Drugs by trial phase (5 distinct, 9 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (14)

Details

Founded
Irvine, CA, US
Last known activity
May 14, 2025